<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>97(33)</volume><submitter>Zhang ZH</submitter><pubmed_abstract>The study is aiming to evaluate the treatment safety and efficacy of greenlight laser photovaporization of the prostate (PVP) combined with transurethral electrovaporization resection (TUVP) for elderly (≥ 70 years) men with lower urinary tract symptoms due to benign prostatic hyperplasia (BPH/LUTS) with a large prostate volume (≥ 80 mL). One hundred twelve BPH/LUTS patients treated with PVP were divided into 2 groups according to prostate volume (PV), the outcomes of the 2 groups were assessed at 12 months after the operation. Patients in the PV ≥ 80 group (n = 51) had a higher level of maximum detrusor pressure (Pdet.max) than those in the PV &lt; 80 group (n = 61) (97.14  ±  36.68 vs 70.70 ± 32.55, P &lt; .001). Pdet.max level of the 2 groups was significantly decreased at the end of follow-up. International Prostate Symptom Score questionnaires (IPSS) score, maximum flow rate (Qmax), and residual urine volume (PVR) were significantly improved in comparison to the preoperative status (P &lt; .001). PVP combined with TUVP can significantly improve outcomes (IPSS, Qmax, PVR) and is a safe and effective technique for elderly BPH/LUTS patients with a large prostate volume.</pubmed_abstract><journal>Medicine</journal><pagination>e11862</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6112907</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Management of greenlight laser plus transurethral resection of prostate for elderly men.</pubmed_title><pmcid>PMC6112907</pmcid><pubmed_authors>Li J</pubmed_authors><pubmed_authors>Zhang ZH</pubmed_authors><pubmed_authors>Luo F</pubmed_authors><pubmed_authors>Su YH</pubmed_authors></additional><is_claimable>false</is_claimable><name>Management of greenlight laser plus transurethral resection of prostate for elderly men.</name><description>The study is aiming to evaluate the treatment safety and efficacy of greenlight laser photovaporization of the prostate (PVP) combined with transurethral electrovaporization resection (TUVP) for elderly (≥ 70 years) men with lower urinary tract symptoms due to benign prostatic hyperplasia (BPH/LUTS) with a large prostate volume (≥ 80 mL). One hundred twelve BPH/LUTS patients treated with PVP were divided into 2 groups according to prostate volume (PV), the outcomes of the 2 groups were assessed at 12 months after the operation. Patients in the PV ≥ 80 group (n = 51) had a higher level of maximum detrusor pressure (Pdet.max) than those in the PV &lt; 80 group (n = 61) (97.14  ±  36.68 vs 70.70 ± 32.55, P &lt; .001). Pdet.max level of the 2 groups was significantly decreased at the end of follow-up. International Prostate Symptom Score questionnaires (IPSS) score, maximum flow rate (Qmax), and residual urine volume (PVR) were significantly improved in comparison to the preoperative status (P &lt; .001). PVP combined with TUVP can significantly improve outcomes (IPSS, Qmax, PVR) and is a safe and effective technique for elderly BPH/LUTS patients with a large prostate volume.</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Aug</publication><modification>2025-05-29T19:00:00.385Z</modification><creation>2025-05-29T19:00:00.385Z</creation></dates><accession>S-EPMC6112907</accession><cross_references><pubmed>30113481</pubmed><doi>10.1097/MD.0000000000011862</doi></cross_references></HashMap>